[1]
|
P. M. Hanno, J. R. Landis, Y. Matthews-Cook, J. Kusek, and L. Nyberg Jr., “The Diagnosis of Interstitial Cystitis Revised; Lessons Learned from the National Institute of Health Interstitial Cystitis Database Study,” The Journal of Urology, Vol. 161, No. 2, 1999, pp. 553-557.
doi:10.1016/S0022-5347(01)61948-7
|
[2]
|
J. P. van de Merwe, J. Nordling, P. Bouchelouche, et al., “Diagnostic Criteria, Classification, and Nomenclature for Painful Bladder Syndrome/Interstitial Cystitis: An ESSIC Proposal,” European Urology, Vol. 53, No. 1, 2008, pp. 60-67.
doi:10.1016/j.eururo.2007.09.019
|
[3]
|
M. Fall, F. Oberpenning and R. Peeker, “Treatment of Bladder Pain Syndrome/Interstitial Cystitis 2008: Can We Make Evidence-Based Decisions?” European Urology, Vol. 54, No. 1, 2008, pp. 65-78.
doi:10.1016/j.eururo.2008.03.086
|
[4]
|
T. C. Lau and J. M. Bengtson, “Management Strategies for Painful Bladder Syndrome,” Reviews in Obstetrics & Gynecology, Vol. 3, No. 2, 2010, pp. 42-48.
|
[5]
|
R. Taneja, “Intravesical Lignocaine in the Diagnosis of Bladder Pain Syndrome,” International Urogynecology Journal, Vol. 21, No. 3, 2010, pp. 321-324.
doi:10.1007/s00192-009-1045-0
|
[6]
|
P. M. Hanno, D. A. Burks, J. Q. Clemens, et al., “Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome,” 2011.
http://www.auanet.org/content/clinical-practice-guidelines/clinical-guidelines/main-reports/ic-bps/diagnosis_and_treatment_ic-bps.pdf
|
[7]
|
M. P. O’Leary, G. R. Sant, F. J. Fowler Jr., K. E. Whitmore and J. Spolarich-Kroll, “The Interstitial Cystitis Symptom Index and Problem Index,” Urology, Vol. 49, No. 5A, 1997, pp. 58-63.
doi:10.1016/S0090-4295(99)80333-1
|
[8]
|
J. Nordling, M. Fall and P. M. Hanno, “Global Concepts of Bladder Pain Syndrome (Interstitial Cystitis),” World Journal of Urology, Vol. 30, No. 4, 2012, pp. 457-464.
doi:10.1007/s00345-011-0785-x
|
[9]
|
G. Chiang, P. Patra, R. Letourneau, et al., “Pentosanpolysulfate Inhibits Mast Cell Histamine Secretion and Intracellular Calciumion Levels: An Alternative Explanation of Its Beneficial Effect in Interstitial Cystitis,” The Journal of Urology, Vol. 164, No. 6, 2000, pp. 2119-2125.
doi:10.1016/S0022-5347(05)66981-9
|
[10]
|
C. L. Parsons, T. Housley, J. D. Schmidt and D. Lebow, “Treatment of Interstitial Cystitis with Intravesical Heparin,” British Journal of Urology, Vol. 73, No. 5, 1994, pp. 504-507. doi:10.1111/j.1464-410X.1994.tb07634.x
|
[11]
|
T. Ueda, M. Tamaki, O. Ogawa, T. Yamauchi and N. Yoshimura, “Improvement of Interstitial Cystitis Symptoms and Problems That Developed during Treatment with Oral IPD-1151T,” The Journal of Urology, Vol. 164, No. 6, 2000, pp. 1917-1920.
doi:10.1016/S0022-5347(05)66917-0
|
[12]
|
M. Lazzeri, M. Spinelli, P. Beneforti, et al., “Intravesical Infusion of Resiniferatoxin by a Temporary in situ Drug Delivery System to Treat Interstitial Cystitis: A Pilot Study,” European Urology, Vol. 45, No. 1, 2004, pp. 98-102.
doi.org/10.1016/S0302-2838(03)00418-4
|
[13]
|
D. Pode, E. Zylber-Kats and A. Shapiro, “Intravesical Lidocaine: Topical Anesthesia for Bladder Mucosal Biopsies,” The Journal of Urology, Vol. 148, No. 3, 1992, pp. 795-796.
|
[14]
|
R. Henry, L. Patterson, N. Avery, et al., “Absorption of Alkalinized Intravesical Lidocaine in Normal and Inflamed Bladders: A Simple Method for Improving Bladder Anesthesia,” The Journal of Urology, Vol. 165, No. 6, 2001, pp. 1900-1903.
|
[15]
|
J. C. Nickel, R. Moldwin, S. Lee, E. L. Davis, R. A. Henry and M. G. Wyllie, “Intravesical Alkalinized Lidocaine (PDS597) Offers Sustained Relief from Symptoms of Interstitial Cystitis and Painful Bladder Syndrome,” BJU International, Vol. 103, No. 7, 2009, pp. 910-918.
doi:10.1111/j.1464-410X.2008.08162.x
|
[16]
|
B. K. Welk and J. M. H. Teichman, “Dyspareunia Response in Patients with Interstitial Cystitis Treated with Intravesical Lidocaine, Bicarbonate, and Heparin,” Urology, Vol. 71, No. 1, 2008, pp. 67-70.
doi:10.1016/j.urology.2007.09.067
|
[17]
|
T. Gurpinar, H. Y. Wong and D. P. Griffith, “Electromotive Administration of Intravesical Lidocaine in Patients with Interstitial Cystitis,” Journal of Endourology, Vol. 10, No. 5, 1996, pp. 443-447.
doi:10.1089/end.1996.10.443
|
[18]
|
G. T. Tucker and L. E. Mather, “Properties, Absorption, and Disposition of Local Anesthetic Agents,” In: M. J. Cousins, P. O. Bridenbaugh and E. D. Neural, Eds., Blockage in Clinical Anesthesia and Management of Pain, Lippincott-Raven, Philadelphia, 1998, pp. 55-86.
|
[19]
|
H. Lee and M. J. Cima, “An Intravesical Device for the Sustained Delivery of the Bladder,” Journal of Controlled Release, Vol. 149, No. 2, 2011, pp. 133-139.
doi:10.1016/j.jconrel.2010.10.016
|
[20]
|
J. C. Nickel, P. Jain, N. Shore, et al., “Continuous Intravesical Lidocaine Treatment for Interstitial Cystitis/Bladder Pain Syndrome: Safety and Efficacy of a New Drug Delivery Device,” Science Translational Medicine, Vol. 4, No. 143, 2012, p.143ra100.
doi:10.1126/scitranslmed.3003804
|